Indefinite Delivery Contract 75N93021D00032
Award Date
9/1/21
Last Date to Order
8/31/28
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
The Emmes Company LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to FHI Clinical Inc. to provide comprehensive and rapid response research programs. The contract has a potential value of $545,452,906 over a seven-year ordering period through August 2028. Two task orders have been issued against it to date, one for $332,178 and another for $2,000. Under the contract, FHI Clinical Inc. will support the NIAID's mission to conduct biomedical research on infectious,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...
The National Institute of Allergy and Infectious Diseases awarded a single award Indefinite Delivery Contract to Booz Allen Hamilton Inc. with a potential value of $545,452,906 to provide comprehensive and rapid response services supporting NIAID's research programs through August 2028. A $2,000 firm fixed price delivery order was also awarded against the contract for unspecified Task Area D services in Bethesda, Maryland from September 2021 through August 2022. The original solicitation...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Camris International, LLC to support biomedical research programs. The contract vehicle has a potential value of $545,452,906 to be obligated against through task orders over a seven-year ordering period ending August 2028. Two task orders have been awarded to date under the contract: one for $545,232 for current good manufacturing practice process development of a trachoma vaccine in Bethesda,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to Leidos, Inc. operating as Saic to provide comprehensive and rapid response services supporting research programs. With a potential value of $545,452,906 over seven years ending August 2028, the multiple award contract vehicle enables delivery orders for clinical trials, manufacturing, animal studies, analytics, storage, and basic research. Leidos was issued an...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery/indefinite-quantity contract to Bioqual, Inc. valued at $545 million with a period of performance from September 2021 to August 2028. Task orders issued against the contract include a $2,000 firm fixed price order to Bioqual for comprehensive and rapid response services in Bethesda, Maryland from September 2021 to August 2022. The original solicitation sought proposals for a...
The National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to Mriglobal, doing business as Midwest Research Institute, with a potential value of $545,452,906 and period of performance from September 1, 2021 through August 31, 2028. The contract provides comprehensive and rapid response services to support NIAID's research programs including clinical trials, manufacturing, nonclinical studies, analytics, and basic research. A $2,000 firm fixed...
The key products and services being delivered under this Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The Emmes Company LLC include comprehensive support services for biomedical research, with a focus on clinical trials and public health initiatives. The $24.5 million single-award IDC, set aside for small businesses, provides a broad range of services such as biostatistical analysis, epidemiological studies, data management,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $146,300,000 to The Johns Hopkins University to provide pre-clinical models of infectious diseases. The contract has a period of performance from July 2024 to July 2031. The contract encompasses four task areas: (A) Small Animal Models, (B) Non-Human Primate Models, (C) Animal Replacement and Non-Traditional Animal Models, and (D) Generation and Distribution...